ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
Paradigm (PAR) - First Ross River Trial Participant Treated
Published: 09/08/17, 09:20am (AEST)•2 pages